Letter to the Editor

Ceruloplasmin Status in Medullary Thyroid Carcinoma

1. Gilliand F, Hunt W, Orris D, Key C (1997). Prognostic factors for thyroid carcinoma: a population based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer, 79:564-73.
2. Nozhat Z, Hedayati M (2016). Medullary thyroid carcinoma: a review on ethical considerations in treatment of children. J Pediatr Endocrinol Metab, 29(6):633-9.
3. Arner E, Forrest AR, Ehrlund A et al (2014). Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS One, 9(3):e80274.
4. Jabbari S, Hedayati M, Yaghmaei P, Parivar K (2015). Medullary Thyroid Carcinoma—Circulating Status of Vaspin and Retinol Binding Protein-4 in Iranian Patients. Asian Pac J Cancer Prev, 16(15):6507-12.
5. Abooshahab R, Yaghmaei P, Ghadaksaz HG, Hedayati M (2016). Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer. Asian Pac J Cancer Prev, 17(8):3861-4.
IssueVol 49 No 1 (2020) QRcode
SectionLetter to the Editor
DOI https://doi.org/10.18502/ijph.v49i1.3078

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
RAZAVI F, SHEIKHOLESLAMI S, ZARIF YEGANEH M, NAJI T, HEDAYATI M. Ceruloplasmin Status in Medullary Thyroid Carcinoma. Iran J Public Health. 2020;49(1):209-210.